Ondansetron in patients requiring anti-emetics a review of clinical effectiveness, cost-effectiveness, and guidelines
This report aims to identify and summarize evidence on the comparative clinical effectiveness of oral versus injectable ondansetron formulations in adult patients requiring medication to control nausea or vomiting. An additional objective is to synthesize evidence on the comparative clinical effecti...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
2020, July 23, 2020
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This report aims to identify and summarize evidence on the comparative clinical effectiveness of oral versus injectable ondansetron formulations in adult patients requiring medication to control nausea or vomiting. An additional objective is to synthesize evidence on the comparative clinical effectiveness and cost-effectiveness of ondansetron versus other anti-emetic agents for palliative patients, as well as evidence-based guidelines for the use of ondansetron to control nausea or vomiting in that population |
|---|---|
| Physical Description: | 1 PDF file (16 pages) illustration |